Related Experiment Video
Updated: Jun 18, 2026

RNA Isolation from Mouse Ocular Lens Epithelium and Fiber Cell Bulk Masses
Published on: October 10, 2025
Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation
Heinz Jungbluth1, Tom Cullup, Suzanne Lillis
1Clinical Neuroscience Division, King's College, London, UK. Heinz.Jungbluth@gstt.nhs.uk
Abstract:
Dynamin 2 (DNM2)-related dominant centronuclear myopathy is usually a mild disorder, but more severe variants have been associated with mutations affecting the pleckstrin homology (PH) domain of the protein, mainly implicated in different forms of Charcot-Marie-Tooth Disease (CMT). Whilst DNM2-related CMT may feature non-neurological findings including cataracts, this has not been reported in DNM2-related centronuclear myopathy. We report a girl presenting from birth with hypotonia, respiratory and feeding difficulties. Motor development was delayed and at 9years she lost the ability to walk. She had ptosis, external ophthalmoplegia and bilateral cataracts. Muscle biopsy showed increase in central nuclei with type 1 hypotrophy and fibrosis. DNM2 screening revealed a novel heterozygous substitution (c.1862T>C; p.Leu621Pro) affecting the PH domain of the protein. Her further course was progressive and at 14years she died from respiratory failure. Our findings expand the phenotypical spectrum associated with DNM2 mutations and provide a new clinical indicator for involvement of this gene in patients with centronuclear myopathy.
Insights
Dynamin 2 (DNM2) gene mutations can cause severe centronuclear myopathy, a rare muscle disorder. This study identifies a novel mutation linked to severe symptoms and cataracts, expanding the known disease spectrum.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Dynamin 2 (DNM2) mutations are linked to dominant centronuclear myopathy (CNM) and Charcot-Marie-Tooth Disease (CMT).
- Severe CNM variants are often associated with mutations in the DNM2 pleckstrin homology (PH) domain.
- Non-neurological symptoms like cataracts are known in DNM2-related CMT but not typically in DNM2-related CNM.
Observation:
- A girl presented with congenital hypotonia, respiratory and feeding issues, delayed motor development, and progressive loss of ambulation.
- She developed ptosis, external ophthalmoplegia, and bilateral cataracts.
- Muscle biopsy revealed central nuclei, type 1 fiber hypotrophy, and fibrosis.
Findings:
- Genetic analysis identified a novel heterozygous DNM2 mutation (c.1862T>C; p.Leu621Pro) in the PH domain.
- This mutation was associated with a severe, progressive phenotype in the patient.
- The patient died at 14 years old due to respiratory failure.
Implications:
- This case expands the phenotypic spectrum of DNM2-related CNM.
- Bilateral cataracts may serve as a clinical indicator for DNM2 gene involvement in CNM patients.
- Understanding genotype-phenotype correlations in DNM2 mutations is crucial for diagnosis and management.
Related Concept Videos
Mechanism of Ciliary Motion
The cilia are made up of microtubules in a 9+2 arrangement, with nine microtubule doublet ring bundles, surrounding a pair of central singlet microtubule bundles. The doublet microtubule bundles are...
Animal Mitochondrial Genetics
Cardiomyopathy II: Dilated Cardiomyopathy
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cardiomyopathy III: Hypertrophic Cardiomyopathy